Amyloid Imaging in Dementia and Neurodegenerative Disease

Keyphrases

• Alzheimer's Disease 100%
• Amyloid Deposition 33%
• Amyloid Imaging 100%
• Amyloid PET 50%
• Amyloid-β Peptide 16%
• Anti-amyloidogenic 16%
• Clinical Impact 16%
• Clinical Practice 16%
• Co-pathology 16%
• Comorbid 16%
• Dementia 16%
• Dementia Diseases 100%
• Dementia with Lewy Bodies 16%
• Diagnostic Tool 16%
• Disease Pathophysiology 16%
• Etiology 16%
• Histological Examination 16%
• Hyperphosphorylated tau Protein 16%
• Image Interpretation 16%
• Interpretation Methodology 16%
• Mixed Dementia 16%
• Mixed Pathology 16%
• Neurodegeneration 16%
• Neurodegenerative Diseases 100%
• Neuropathology 33%
• Neuropsychological Tests 16%
• Ongoing Trials 16%
• Patient Symptoms 16%
• Peptide Aggregates 16%
• PET Tracer 33%
• Specific Image 16%
• Therapeutic Efficacy 16%
• Therapy Efficacy 16%
• Vascular Dementia 16%

Medicine and Dentistry

• Alzheimer's Disease 50%
• Amyloid Protein 100%
• Combination Therapy 10%
• Degenerative Disease 100%
• Lewy Body 10%
• Neurodegeneration 10%
• Neuropathology 10%
• Neuropsychological Testing 10%
• Pathophysiology 10%
• Polyethylene Terephthalate 20%
• Positron Emission Tomography 10%
• Sensitivity and Specificity 10%
• Tau Protein 10%
• Treatment of Alzheimer's Disease 10%
• Vascular Dementia 10%